Institutional development · Research, innovation and assessment · Brazil
Study of 2,396 São Paulo lymphoma cases finds lower survival among public-system patients
A study reported by Unesp's newsroom examined 2,396 cases of an aggressive lymphoma treated in São Paulo's public and private networks and found lower survival among patients treated through SUS.
Why it matters: Patients with aggressive lymphoma treated through SUS in São Paulo are the group the study found to have lower survival.
Unesp's newsroom reported a study that identifies inequalities in survival between lymphoma patients treated in São Paulo's public and private health networks.
According to the report, the study analysed 2,396 cases of an aggressive form of lymphoma, a disease affecting immune-system cells.
The report states that patients treated through SUS, Brazil's public Unified Health System, had lower survival.
Editor’s view
Scott James, Research and Innovation Editor
The finding concerns patients with an aggressive lymphoma in São Paulo: according to the study, those treated through SUS had lower survival, across the 2,396 cases analysed.
